- Home
- OXM vs AUTL Comparison
OXM vs AUTL Comparison
Compare OXM & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OXM | AUTL |
|---|---|---|
| Founded | 1942 | 2014 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Apparel | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 543.0M | 596.2M |
| IPO Year | 1994 | 2025 |
Fundamental Metrics
Financial Performance| Metric | OXM | AUTL |
|---|---|---|
| Price | $25.39 | $1.62 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 9 |
| Target Price | ★ $34.00 | $8.73 |
| AVG Volume (30 Days) | 525.4K | ★ 1.4M |
| Earning Date | 09-03-2026 | 11-11-2026 |
| Dividend Yield | ★ 11.08% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.25 | N/A |
| Revenue | ★ $1,477,834,000.00 | $10,120,000.00 |
| Revenue This Year | N/A | $98.68 |
| Revenue Next Year | $2.29 | $28.47 |
| P/E Ratio | $5.95 | ★ N/A |
| Revenue Growth | N/A | ★ 496.00 |
| 52 Week Low | $24.20 | $1.18 |
| 52 Week High | $49.58 | $2.58 |
Technical Indicators
Market Signals| Indicator | OXM | AUTL |
|---|---|---|
| Relative Strength Index (RSI) | 31.62 | 31.97 |
| Support Level | $24.20 | $1.37 |
| Resistance Level | $26.06 | $1.73 |
| Average True Range (ATR) | 0.93 | 0.09 |
| MACD | 0.33 | -0.02 |
| Stochastic Oscillator | 48.76 | 0.00 |
Price Performance
Historical ComparisonAbout OXM Oxford Industries Inc.
Oxford Industries Inc is an apparel manufacturing company that designs, sources, markets, and distributes products under the brand name Tommy Bahama, and Lilly Pulitzer. Tommy Bahama designs, sources, markets, and distributes men's and women's sportswear and related products. Lilly Pulitzer designs, sources, markets, and distributes upscale collections of women's and women's dresses, sportswear, and related products. The company's business is organized as: Tommy Bahama, Lilly Pulitzer, Johnny Was and Emerging Brands reportable segments. Geographically, the company operates in United States as well as Internationally.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8. Company's T cell programming technologies tailors therapies to address the specific disease targeting and introduce new programming modules into a patient's T cells to give those T cells improved properties to recognize target cells and overcome fundamental disease defense mechanisms.